Accessibility statement

Improving the management of children and young people with cancer

Childhood cancer is rare: 1 in 600 children will develop a malignancy before 16 years of age. Cure is possible though, and with aggressive treatments the cure rate is around 80% in Europe and North America.

We can improve survival and quality of life by making diagnoses more accurate, and by preventing and treating complications from the therapies we use. The CRD team are involved in a series of studies examining how we prevent and manage the complications of childhood cancer therapies. Our main work is on potential life threatening infections in children with cancer, including the NIHR funded PICNICC study. We also work on improving the management of chemotherapy induced nausea and vomiting, nutritional support, and psychological support interventions. The CRD team works in collaboration to develop the methods of undertaking such research, to make it more effective and efficient. The expertise of the team has been sought in international collaborations examining diagnostic technologies and assessing and reducing the adverse effects of different cancer treatments.

We are always keen to discuss research collaborations or fellowships in this area: please contact bob.phillips@york.ac.uk by email or Twitter @drbobphillips if you'd like to find out more.